Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Sarah Campion"'
Autor:
Sarah Campion, Amy Inselman, Belinda Hayes, Costanza Casiraghi, David Joseph, Fabrizio Facchinetti, Fabrizio Salomone, Georg Schmitt, Julia Hui, Karen Davis-Bruno, Karen Van Malderen, LaRonda Morford, Luc De Schaepdrijver, Lutz Wiesner, Stephanie Kourula, Suna Seo, Susan Laffan, Vijay Urmaliya, Connie Chen
Publikováno v:
Disease Models & Mechanisms, Vol 15, Iss 4 (2022)
Increased research to improve preclinical models to inform the development of therapeutics for neonatal diseases is an area of great need. This article reviews five common neonatal diseases – bronchopulmonary dysplasia, retinopathy of prematurity,
Externí odkaz:
https://doaj.org/article/2b780bb945cf480c8f579328eb912ef4
Autor:
Sarah Campion, Lénora Lardy
Publikováno v:
Miranda: Revue Pluridisciplinaire du Monde Anglophone, Vol 14 (2017)
Externí odkaz:
https://doaj.org/article/33a9fcf550cb4a419de6e00d1563cda5
Autor:
Jiangwei Zhang, Sarah Campion, Natasha Catlin, William J. Reagan, Kiran Palyada, Shashi K. Ramaiah, Ragu Ramanathan
Publikováno v:
Archives of Toxicology. 97:947-961
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::452f2e569b9a5ceb38e406624dd63a40
https://doi.org/10.1007/s00204-023-03460-0
https://doi.org/10.1007/s00204-023-03460-0
Autor:
Tacey E.K. White, Joy Cavagnaro, Cindy L. Berman, Sarah Campion, Scott P. Henry, Doug Kornbrust
Publikováno v:
Nucleic Acid Therapeutics. 24:313-325
This white paper summarizes the current consensus of the Reproductive Subcommittee of the Oligonucleotide Safety Working Group on strategies to assess potential reproductive and/or developmental toxicities of therapeutic oligonucleotides (ONs). The u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f7f929eebc14661c688bcdb23d0a5b
https://doi.org/10.1089/nat.2014.0490
https://doi.org/10.1089/nat.2014.0490
Publikováno v:
Journal of Orthopaedic Research. 24:2051-2058
These studies evaluated whether F2A4-K-NS, a peptide mimetic of FGF-2, could augment ectopic bone production following the subcutaneous implant of human demineralized bone matrix (DBM). DBM was formulated into a gel with and without F2A4-K-NS, and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c07c3fb0f8beadd3268d40997a30de9a
https://doi.org/10.1002/jor.20215
https://doi.org/10.1002/jor.20215
Autor:
Ravi Murthi, Vivek Subbiah, Chitra Hosing, Marnix L. Bosch, Aung Naing, Sarah Campion, David S. Hong, Siqing Fu, Robert S. Brown, Anthony P. Conley, Robert M. Prins, Mary F. McGuire, Kyle Hendricks, Lori Noffsinger, Indreshpal Kaur
Publikováno v:
Cancer Immunology Research. 4:B005-B005
Background: Activated, autologous dendritic cells (aaDC) can be used to induce anti-tumor immune responses. A unique method of applying aaDC is through intratumoral injection, where the tumor cells serve as the source of antigen required for an adapt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::062e5f6ae65fd34e6219d38c52c9b065
https://doi.org/10.1158/2326-6066.imm2016-b005
https://doi.org/10.1158/2326-6066.imm2016-b005
Autor:
Xinhua Lin, Paul O. Zamora, J.J. Elliot, Louis A. Peña, Kazuyuki Takahashi, Brent Atkinson, D.L. Carnes, Sarah Campion, W.C. Fox
Publikováno v:
Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 25(4)
The synthetic peptide B2A2-K-NS augmented the in vitro expression of osseous phenotypes when cells were stimulated with BMP-2, an osteoinductive growth factor. B2A2-K-NS significantly enhanced the effects of BMP-2-induced alkaline phosphatase activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87aaec4cc5d734fcd295e56701b9b95
https://pubmed.ncbi.nlm.nih.gov/17149745
https://pubmed.ncbi.nlm.nih.gov/17149745
Publikováno v:
International Journal of Molecular Medicine.
A multi-domain synthetic peptide, F2A4-K-NS, mimicked the action of recombinant human FGF-2 (rhFGF-2) in vitro and in an in vivo model of angiogenesis. Like rhFGF-2, F2A4-K-NS was quantitatively shown to bind to FGF receptors in a cell-free receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e7bb186fa6d62f1fe7a68ae090bd0c
https://doi.org/10.3892/ijmm.17.5.833
https://doi.org/10.3892/ijmm.17.5.833